Drug Interactions with New and Investigational Antiretrovirals

被引：7

作者：

Crauwels, Herta M. ^{[1
]}

Kakuda, Thomas N. ^{[2
]}

机构：

[1] Tibotec BVBA, Mechelen, Belgium

[2] Tibotec Inc, Yardley, PA USA

来源：

关键词：

Fluconazole; Itraconazole; Dose Adjustment; Ketoconazole; Nucleoside Analogue;

D O I：

10.2165/11531240-000000000-00000

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：67 / 68

页数：2

共 12 条

[1] Brown KC, 2009, CLIN PHARMACOKINET, V48, P554
[2] Drug Interactions with New and Investigational Antiretrovirals
Brown, Kevin C.
Paul, Sunita
Kashuba, Angela D. M.
[J]. CLINICAL PHARMACOKINETICS, 2009, 48 (04) : 211 - 241
[3] HOETELMANS R, 2005, 10 EUR AIDS C NOV 17
[4] *JANSS CIL LTD, 2009, INT ETR TABL SUMM PR
[5] Assessment of the steady-state pharmacokinetic interaction between etravirine administered as two different formulations and tenofovir disoproxil fumarate in healthy volunteers
Kakuda, T. N.
Scholler-Gyure, M.
De Smedt, G.
Beets, G.
Aharchi, F.
Peeters, M. P.
Vandermeulen, K.
Woodfall, B. J.
Hoetelmans, R. M. W.
[J]. HIV MEDICINE, 2009, 10 (03) : 173 - 181
[6] PISCITELLI SC, 2002, 42 INT C ANT AG CHEM
[7] Scholler-Gyure M.KakudaTN, 2009, 49 INT C ANT AG CHEM
[8] SCHOLLERGYURE M, 2006, 8 INT C DRUG THER HI
[9] *TIB INC, 2008, INT ETR TABL US PRES
[10] *TIB PHARM IR, TMC125 TIDP2 C238 EX